Article
Mylan, Pfizer's $12B Viatris merger clears FTC with deal for product selloffs
Rating:
0.0
Views:
76
Likes:
1
Library:
1
Fifteen months since the deal announcement, Mylan and Pfizer can finally move ahead with their generics merger after a COVID-related delay and a closer examination by U.S. antitrust regulators that has now ended with a settlement for product selloffs.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value